查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606422

植入前基因診斷市場，按類型、技術、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Preimplantation Genetic Diagnosis Market, By Type, By Technology, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，植入前基因診斷市值為5,780萬美元，2024年至2032年複合年成長率為7.80%。

植入前基因診斷市場-市場動態

遺傳性疾病盛行率的上升預計將推動市場的成長

植入前遺傳學診斷 (PGD) 提供了一個重要的解決方案，能夠選擇沒有某些遺傳異常的胚胎。這種對促進健康分娩的重視鼓勵越來越多的夫妻將 PGD 納入他們的生殖策略。根據世界衛生組織的數據，在已開發國家，遺傳性疾病和先天異常佔所有活產嬰兒的約 2%-5%，佔兒科住院人數的近 30%，並導致約 50% 的兒童死亡。

此外，生育診所的擴張和基因檢測技術的不斷進步可能會為市場帶來成長機會。然而，PGD 服務相關的高成本可能會阻礙市場擴張。

植入前基因診斷市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 7.80% 左右的複合年成長率成長

根據類型細分，預計非整倍體將在 2023 年顯示最大的市場佔有率

從技術細分來看，聚合酶鍊式反應（PCR）是2023年的主導類型

根據最終用戶細分，醫院是 2023 年的領先類型

按地區分類，北美是 2023 年的主要收入來源

植入前基因診斷市場-細分分析：

全球植入前基因診斷市場根據類型、技術、最終用戶和地區進行細分。

市場依類型分為六類：染色體異常、非整倍體、X連鎖疾病、單基因疾病、HLA分型、性別選擇等。有關非整倍體的細分市場在市場上佔據主導地位。非整倍體可能導致發育障礙、流產或先天異常。因此，其鑑定對於尋求體外受精的家庭至關重要。

根據技術，市場分為三個部分：下一代定序（NGS）、聚合酶鏈反應（PCR）、螢光原位雜合技術（FISH）和其他方法。聚合酶鍊式反應（PCR）在市場上佔據領先地位。這種強大的分子生物學技術用於擴增特定的 DNA 序列，使其成為植入前遺傳診斷 (PGD) 等基因檢測的重要工具。

根據最終用戶，市場分為四大類：生育中心、醫院、診斷中心、研究中心、學術實驗室等。醫院板塊引領市場。醫院提供關鍵的臨床服務，例如 IVF 程序，這通常是 PGD 過程的初始階段。醫院內專門的生殖健康部門的存在提高了尋求基因檢測的患者獲得PGD的機會。

植入前基因診斷市場-地理洞察

北美憑藉其尖端的醫療技術引領了市場擴張。該地區因擁有全球一些最先進的醫療技術和研究機構而聞名。對創新基因檢測方法（包括下一代定序（NGS）和高通量篩檢技術）的大量投資，顯著提高了 PGD 的效率和精確度，使其成為患者和醫療保健專業人員的青睞選擇。美國是全球最大的醫療器材市場，佔全球醫療技術領域的40%以上。歐洲在市場佔有率方面緊隨其後，而在不孕率上升和醫療基礎設施進步的推動下，亞太地區表現出巨大的成長潛力。

植入前基因診斷市場-競爭格局：

植入前基因診斷 (PGD) 市場呈現出一個競爭激烈的環境，其特點是眾多知名參與者、技術創新以及對基因篩檢服務日益成長的需求。專注於基因檢測的組織對於 PGD 市場至關重要，為胚胎評估提供必要的技術和專業知識。 PGD​​ 市場的競爭動態很大程度取決於技術的進步。創造更有效和更精確的基因檢測方法（包括下一代定序 (NGS) 和多重 PCR）的公司可以確保競爭優勢。持續的創新有助於提高識別遺傳異常的敏感性和特異性。

最新進展：

德州奧斯汀 Natera, Inc. 是無細胞 DNA 和基因檢測領域的全球知名實體，該公司宣布將公佈有關其個性化和腫瘤資訊分子殘留疾病 (MRD) 檢測 Signatera 的新發現。 2024 年歐洲腫瘤內科學會(ESMO) 大會定於9 月13 日至16 日在西班牙巴塞隆納舉行。

目錄

第1章：植入前基因診斷市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的植入前基因診斷市場片段
    • 植入前基因診斷市場片段（依技術）
    • 最終用戶的植入前基因診斷市場片段
    • 按國家/地區分類的植入前基因診斷市場片段
    • 按地區分類的植入前基因診斷市場片段
  • 競爭洞察

第 3 章：植入前基因診斷主要市場趨勢

  • 植入前基因診斷市場促進因素
    • 市場促進因素的影響分析
  • 植入前基因診斷市場限制
    • 市場限制影響分析
  • 植入前基因診斷市場機會
  • 植入前基因診斷市場未來趨勢

第4章：胚胎植入前基因診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：植入前基因診斷市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：植入前基因診斷市場格局

  • 2023 年植入前基因診斷市佔分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：植入前基因診斷市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 染色體異常
    • 非整倍體
    • X連鎖疾病
    • 單基因疾病
    • HLA分型
    • 性別選擇
    • 其他

第 8 章：植入前基因診斷市場 - 按技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 次世代定序 (NGS)
    • 聚合酶鍊式反應 (PCR)
    • 螢光原位雜合技術 (FISH)
    • 其他

第 9 章：植入前基因診斷市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 生育中心
    • 醫院
    • 診斷中心
    • 研究中心和學術實驗室
    • 其他

第 10 章：植入前基因診斷市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美植入前基因診斷主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲植入前基因診斷主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區胚胎植入前基因診斷主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按技術）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲植入前基因診斷主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲植入前基因診斷主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第11章：主要供應商分析-植入前基因診斷產業

  • 競爭儀表板
  • 公司簡介
    • Quest Diagnostics Incorporated
    • Natera, Inc.
    • COOPER SURGICAL, INC.
    • Genea Pty Limited.
    • Invitae Corporation
    • Laboratory Corporation of America Holdings
    • Thermo Fisher Scientific Inc.
    • Bioarray SL
    • Illumina, Inc.
    • Igenomix
    • RGI
    • F. Hoffmann-La Roche Ltd
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4228

REPORT HIGHLIGHT

The Preimplantation Genetic Diagnosis Market was valued at USD 57.80 Million in 2023 and expanded at a CAGR of 7.80% from 2024 to 2032.

Pre-implantation genetic diagnosis (PGD) is a laboratory technique employed alongside in vitro fertilization (IVF) to minimize the likelihood of transmitting hereditary disorders. The primary motivations for utilizing PGD include the presence of particular single-gene disorders, such as polycystic kidney disease, cystic fibrosis, and sickle cell anemia, as well as chromosomal abnormalities in a parent. Additionally, families may opt for PGD when a relative requires a bone marrow donor, enabling them to conceive a child capable of supplying compatible stem cells.

Preimplantation Genetic Diagnosis Market- Market Dynamics

The rising Prevalence of Genetic Disorders is anticipated to drive the growth of the market

Preimplantation Genetic Diagnosis (PGD) offers a significant solution by enabling the selection of embryos free from certain genetic abnormalities. This emphasis on promoting healthy births encourages an increasing number of couples to incorporate PGD into their reproductive strategies. According to the World Health Organization, genetic disorders and congenital anomalies are present in approximately 2%-5% of all live births, contribute to nearly 30% of pediatric hospital admissions, and are responsible for about 50% of childhood fatalities in developed nations.

Additionally, the expansion of fertility clinics and ongoing advancements in genetic testing technologies may present growth opportunities for the market. However, the high costs associated with PGD services could hinder market expansion.

Preimplantation Genetic Diagnosis Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.80% over the forecast period (2024-2032)

Based on Type segmentation, Aneuploidy was predicted to show maximum market share in the year 2023

Based on Technology segmentation, Polymerase Chain Reaction (PCR) was the leading type in 2023

Based on End-User segmentation, the hospital was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Preimplantation Genetic Diagnosis Market- Segmentation Analysis:

The Global Preimplantation Genetic Diagnosis Market is segmented based on Type, Technology, End-User, and Region.

The market is segmented into six categories according to Type: Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender selection, and others. The segment about Aneuploidy holds a dominant position within the market. Aneuploidy may result in developmental challenges, miscarriages, or congenital anomalies. Consequently, its identification is essential for families pursuing in vitro fertilization.

The market is classified into three segments according to technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH), and additional methods. Polymerase Chain Reaction (PCR) holds a leading position in the market. This robust molecular biology technique is employed to amplify particular DNA sequences, rendering it an essential instrument in genetic testing, such as Preimplantation Genetic Diagnosis (PGD).

The market is segmented into four categories according to End-User: Fertility Centers, Hospitals, Diagnostic Centers, Research Centers, Academic Laboratories, and Others. The hospital sector leads the market. Hospitals offer critical clinical services, such as IVF procedures, which frequently serve as the initial phase in the PGD process. The existence of dedicated reproductive health departments within hospitals improves accessibility to PGD for patients pursuing genetic testing.

Preimplantation Genetic Diagnosis Market- Geographical Insights

North America leads the market expansion, attributed to its cutting-edge medical technologies. This region is recognized for hosting some of the most sophisticated medical technologies and research institutions globally. The substantial investment in innovative genetic testing methods, including next-generation sequencing (NGS) and high-throughput screening techniques, significantly improves the efficiency and precision of PGD, rendering it a favored option among patients and healthcare professionals. The United States is the largest medical device market worldwide, accounting for over 40% of the global medtech sector. Europe closely follows in market presence, while the Asia-Pacific region exhibits considerable growth potential, fueled by increasing infertility rates and advancements in healthcare infrastructure.

Preimplantation Genetic Diagnosis Market- Competitive Landscape:

The Preimplantation Genetic Diagnosis (PGD) Market presents a competitive environment marked by several prominent participants, technological innovations, and an increasing need for genetic screening services. Organizations focused on genetic testing are essential to the PGD market, offering the requisite technologies and expertise for embryo evaluation. The competitive dynamics within the PGD market are significantly shaped by advancements in technology. Firms that create more effective and precise genetic testing methodologies, including next-generation sequencing (NGS) and multiplex PCR, secure a competitive advantage. Ongoing innovation contributes to enhanced sensitivity and specificity in identifying genetic anomalies.

Recent Developments:

AUSTIN, Texas Natera, Inc., a prominent global entity in the field of cell-free DNA and genetic testing, has announced that it will unveil new findings regarding its personalized and tumor-informed molecular residual disease (MRD) test, Signatera, at the upcoming 2024 European Society for Medical Oncology (ESMO) Congress, scheduled for September 13-16 in Barcelona, Spain.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PREIMPLANTATION GENETIC DIAGNOSIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Quest Diagnostics Incorporated
  • Natera, Inc.
  • COOPER SURGICAL, INC.
  • Genea Pty Limited.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific Inc.
  • Bioarray S.L.
  • Illumina, Inc.
  • Igenomix
  • RGI
  • F. Hoffmann-La Roche Ltd
  • Others

GLOBAL PREIMPLANTATION GENETIC DIAGNOSIS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Chromosomal Abnormalities
  • Aneuploidy
  • X-linked diseases
  • Single Gene Disorders
  • HLA Typing
  • Gender selection
  • Others

GLOBAL PREIMPLANTATION GENETIC DIAGNOSIS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescent In-Situ Hybridization (FISH)
  • Others

GLOBAL PREIMPLANTATION GENETIC DIAGNOSIS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Fertility Centers
  • Hospitals
  • Diagnostic Centers
  • Research Centers and Academic Labs
  • Others

GLOBAL PREIMPLANTATION GENETIC DIAGNOSIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Preimplantation Genetic Diagnosis Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Preimplantation Genetic Diagnosis Market Snippet by Type
    • 2.1.2. Preimplantation Genetic Diagnosis Market Snippet by Technology
    • 2.1.3. Preimplantation Genetic Diagnosis Market Snippet by End-User
    • 2.1.4. Preimplantation Genetic Diagnosis Market Snippet by Country
    • 2.1.5. Preimplantation Genetic Diagnosis Market Snippet by Region
  • 2.2. Competitive Insights

3. Preimplantation Genetic Diagnosis Key Market Trends

  • 3.1. Preimplantation Genetic Diagnosis Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Preimplantation Genetic Diagnosis Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Preimplantation Genetic Diagnosis Market Opportunities
  • 3.4. Preimplantation Genetic Diagnosis Market Future Trends

4. Preimplantation Genetic Diagnosis Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Preimplantation Genetic Diagnosis Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Preimplantation Genetic Diagnosis Market Landscape

  • 6.1. Preimplantation Genetic Diagnosis Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Preimplantation Genetic Diagnosis Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Chromosomal Abnormalities
    • 7.1.3. Aneuploidy
    • 7.1.4. X-linked diseases
    • 7.1.5. Single Gene Disorders
    • 7.1.6. HLA Typing
    • 7.1.7. Gender selection
    • 7.1.8. Others

8. Preimplantation Genetic Diagnosis Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. Next Generation Sequencing (NGS)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Fluorescent In-Situ Hybridization (FISH)
    • 8.1.5. Others

9. Preimplantation Genetic Diagnosis Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Fertility Centers
    • 9.1.3. Hospitals
    • 9.1.4. Diagnostic Centers
    • 9.1.5. Research Centers and Academic Labs
    • 9.1.6. Others

10. Preimplantation Genetic Diagnosis Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Preimplantation Genetic Diagnosis Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Preimplantation Genetic Diagnosis Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Preimplantation Genetic Diagnosis Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Preimplantation Genetic Diagnosis Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Preimplantation Genetic Diagnosis Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Preimplantation Genetic Diagnosis Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Quest Diagnostics Incorporated
    • 11.2.2. Natera, Inc.
    • 11.2.3. COOPER SURGICAL, INC.
    • 11.2.4. Genea Pty Limited.
    • 11.2.5. Invitae Corporation
    • 11.2.6. Laboratory Corporation of America Holdings
    • 11.2.7. Thermo Fisher Scientific Inc.
    • 11.2.8. Bioarray S.L.
    • 11.2.9. Illumina, Inc.
    • 11.2.10. Igenomix
    • 11.2.11. RGI
    • 11.2.12. F. Hoffmann-La Roche Ltd
    • 11.2.13. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us